Abstract
The operative modes for pulmonary parenchymal resection include pneumonectomy, bilobectomy, lobectomy, segmental resection (segmentectomy), and wedge resection, according to the extent of lung parenchyma to be resected. From the perspective of the technical features at the pulmonary hilum, these may be divided into anatomic (pneumonectomy, bilobectomy, lobectomy, and segmentectomy) and nonanatomic (wedge) resections. In anatomic resection, the extent of pulmonary parenchyma for resection is determined according to the extent of perfusion of pulmonary vessels as well as by the extent of aeration of the bronchi, which are divided at the hilum. On the other hand, in nonanatomic resection, the extent of parenchymal resection is determined solely according to the location of the target lesion. Although segmentectomy and wedge resection are both referred to as sublobar resection, their technical characteristics are quite different.
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Introduction
The operative modes for pulmonary parenchymal resection include pneumonectomy, bilobectomy, lobectomy, segmental resection (segmentectomy), and wedge resection, according to the extent of lung parenchyma to be resected. From the perspective of the technical features at the pulmonary hilum, these may be divided into anatomic (pneumonectomy, bilobectomy, lobectomy, and segmentectomy) and nonanatomic (wedge) resections. In anatomic resection, the extent of pulmonary parenchyma for resection is determined according to the extent of perfusion of pulmonary vessels as well as by the extent of aeration of the bronchi, which are divided at the hilum. On the other hand, in nonanatomic resection, the extent of parenchymal resection is determined solely according to the location of the target lesion. Although segmentectomy and wedge resection are both referred to as sublobar resection, their technical characteristics are quite different.
Almost 70 years ago, Churchill and Belsey introduced segmental resection as “segmental pneumonectomy” for treating benign lung diseases. In 1973, Jensik and colleagues suggested that anatomic pulmonary segmentectomy may be applied effectively to small primary lung cancers when the surgical margins are sufficient. Some subsequent nonrandomized studies showed that excellent outcomes may be achieved with segmental resection in patients with early cancers. These reports stimulated a debate regarding the optimal resection technique for early-stage non–small cell lung cancer, which was addressed in a prospective, randomized trial conducted by the Lung Cancer Study Group (LCSG). Limited pulmonary resection, including anatomic segmentectomy and nonanatomic wide wedge resections, was compared with lobectomy for stage IA lung cancer with regard to postoperative prognosis and pulmonary function. This study solidified lobectomy as the procedure of choice for treating this disease, based on the inferior postoperative survival and increased locoregional recurrence in the limited resection group. This randomized trial is still the only one that directly compared limited resection with lobectomy; therefore, the gold standard for lung cancer is still lobectomy.
In recent years, however, many smaller and pathologically earlier lung cancers have been seen in clinical practice, especially in Japan and the United States, and improvements in CT image quality, the widespread adoption of CT screening programs for lung cancer, and changes in the etiologic factors of lung cancer may underlie this phenomenon. Among the lesions specifically found in this context, the nonsolid lesion referred to as ground glass opacity (GGO) is a newly established clinical entity that may be a candidate for limited pulmonary resection. The term GGO is used to describe noncalcified, subsolid nodules, and the pathobiological nature, natural history, and proper management of GGOs have become matters of greater concern among thoracic surgeons. According to recent studies on the relationship between their appearance in CT images and histopathology, a considerable percentage of these lesions, although not all, are preinvasive, noninvasive, early forms of neoplastic growth, especially those of adenocarcinoma lineage (nonmucinous bronchioloalveolar carcinoma [BAC]), or minimally invasive adenocarcinoma. Thus, for smaller, earlier lung cancers, including GGO-BACs, the indications for segmentectomy are being revised, and recent nonrandomized studies have reported excellent survival.
Randomized clinical trials with peripheral lung cancers no more than 2 cm in diameter as the target lesions were begun in the United States (Cancer and Leukemia Group B) and Japan (Japan Clinical Oncology Group) around the same time. Case accrual and the maturation of prognostic data are eagerly awaited.
Conclusion
Parenchyma-sparing, limited resections are becoming increasingly important in an era in which smaller and earlier lung cancer commonly is found in elderly patients with compromised conditions. Although lobectomy and pneumonectomy remain the mainstay for surgically treating lung cancer after the North American randomized trial in the 1980s, the surgical community must recognize the necessity of reevaluating the technical and prognostic aspects of the sublobar resection in the modern situation. Almost 30 years have passed since the only landmark randomized study, and the workup of patients, as well as their surgical care, has changed drastically.
The controversy regarding limited resection includes the demonstration of the equivalence of prognosis and the functional advantage of sublobar (segmental) resection in terms of pulmonary function versus standard lobectomy. The direct comparison between surgery and sophisticated radiologic techniques such as stereotactic body radiation therapy is another important and interesting issue, although the appropriate “surgery (mode of resection)” in this comparison must be clearly defined.
The technical standardization of the segmental resection, especially regarding the management of intersegmental parenchyma and vein from an oncologic perspective, needs to be addressed in the surgical community. The morbidity due to sublobar resection, such as prolonged air leakage, must be overcome, because these complications necessitate a longer hospital stay.
Selected Bibliography
Ginsberg R, Rubinstein L (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:615–623
Jensik RJ, Faber LP, Milloy FJ, Monson DO (1973) Segmental resection for lung cancer: a fifteen year experience. J Thorac Cardiovasc Surg 63:433–438
Jensik RJ, Faber LP, Kittle CF (1979) Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 28:475–483
Kodama K, Doi O, Higashiyama M, Yokouchi H (1997) International limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 114:347–353
Okada M, Yoshikawa K, Hatta T et al (2001) Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 71:956–961
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Asamura, H. (2015). Anatomic Segmental Resection. In: Dienemann, H., Hoffmann, H., Detterbeck, F. (eds) Chest Surgery. Springer Surgery Atlas Series. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12044-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-12044-2_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12043-5
Online ISBN: 978-3-642-12044-2
eBook Packages: MedicineMedicine (R0)